Florbetaben F-18 Patent Expiration

Florbetaben F-18 is Used for estimating p-amyloid neuritic plaque density in adult patients with cognitive impairment through PET imaging of the brain. It was first introduced by Life Molecular Imaging Ltd in its drug Neuraceq on Mar 19, 2014.


Florbetaben F-18 Patents

Given below is the list of patents protecting Florbetaben F-18, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Neuraceq US7807135 Stilbene derivatives and their use for binding and imaging amyloid plaques Mar 18, 2029 Life Molecular
Neuraceq US7907135 Image display and image displaying method for gradation correction Mar 18, 2029 Life Molecular